歡迎來(lái)到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁(yè) > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗CLN6多克隆抗體

產(chǎn)品中心

  • 兔抗CLN6多克隆抗體

    規(guī)格:
    數(shù)量:

    購(gòu)買(mǎi)數(shù)量

    價(jià)格:
    • 品牌 : 通蔚生物
    • 目錄號(hào) : TW14914
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫(kù)存:75
  • 商品詳情
  • 參考文獻(xiàn)
  • 說(shuō)明書(shū)下載
  • 商品評(píng)論0
  • 相關(guān)產(chǎn)品


中文名稱(chēng):兔抗CLN6多克隆抗體   

英文名稱(chēng):Anti-CLN6 rabbit polyclonal antibody

別      名:nclf; CLN4A; HsT18960

抗      原:CLN6

儲(chǔ)      存:冷凍(-20℃) 避光

宿      主:Rabbit

反應(yīng)種屬:Human

相關(guān)類(lèi)別:一抗

標(biāo) 記 物:Unconjugate

克隆類(lèi)型:Unconjugate

技術(shù)規(guī)格

Background:

This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.

Applications:

WB, IHC

Name of antibody:

CLN6

Immunogen:

Synthesized peptide derived from internal of human CLN6.

Full name:

ceroid-lipofuscinosis, neuronal 6, late infantile, variant

Synonyms:

nclf; CLN4A; HsT18960

SwissProt:

Q9NWW5

IHC positive control:

Human cervix tissue

IHC Recommend dilution:

50-100

WB Predicted band size:

36 kDa

WB Positive control:

Hela cells lysate

WB Recommended dilution:

500-3000